These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 480180)
41. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats. Cundy KC; Bidgood AM; Lynch G; Shaw JP; Griffin L; Lee WA Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571 [TBL] [Abstract][Full Text] [Related]
42. Absorption and excretion of suprofen in rats. Mori Y; Yokoya F; Toyoshi K; Baba S; Sakai Y Drug Metab Dispos; 1983; 11(4):387-91. PubMed ID: 6137348 [TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572 [TBL] [Abstract][Full Text] [Related]
44. Effect of pirprofen on protein binding of warfarin and tolbutamide in human plasma. Luders RC; Chao D J Pharm Sci; 1981 Dec; 70(12):1370-1. PubMed ID: 7320855 [TBL] [Abstract][Full Text] [Related]
45. Disposition of MK-852, a fibrinogen receptor antagonist, in rats and dogs. Vickers S; Duncan CA; Yuan AS; Vyas KP Drug Metab Dispos; 1994; 22(4):631-6. PubMed ID: 7956740 [TBL] [Abstract][Full Text] [Related]
46. Effect of aspirin on fate of 14C-acetaminophen in guinea pigs. Whitehouse LW; Paul CJ; Thomas BH J Pharm Sci; 1975 May; 64(5):819-21. PubMed ID: 1151653 [TBL] [Abstract][Full Text] [Related]
47. Effect of salicylate on the fate of [14C]sulfinpyrazone in the rat. Wong LT; Buttar HS; Solomonraj G; Thomas BH Can J Physiol Pharmacol; 1982 Jun; 60(6):763-8. PubMed ID: 7116223 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of pirprofen in children with juvenile chronic arthritis. Hallé F; Marfil F; Sioufi A; Dubois JP; Gioud-Paquet M; Lenoir G; Prieur AM Eur J Drug Metab Pharmacokinet; 1991; 16(1):29-34. PubMed ID: 1936058 [TBL] [Abstract][Full Text] [Related]
49. Metabolism of alpha-phosphonosulfonate squalene synthase inhibitors. I. Disposition of a farnesylethyl alpha-phosphonosulfonate and ester prodrugs in rats. Lan SJ; Hsieh DC; Hillyer JW; Fancher RM; Rinehart KJ; Warrack BM; White RE Drug Metab Dispos; 1998 Oct; 26(10):993-1000. PubMed ID: 9763405 [TBL] [Abstract][Full Text] [Related]
50. Glucuronidation of 2-arylpropionic acids pirprofen, flurbiprofen, and ibuprofen by liver microsomes. Magdalou J; Chajes V; Lafaurie C; Siest G Drug Metab Dispos; 1990; 18(5):692-7. PubMed ID: 1981722 [TBL] [Abstract][Full Text] [Related]
51. Metabolism and disposition of erythritol after oral administration to rats. Noda K; Oku T J Nutr; 1992 Jun; 122(6):1266-72. PubMed ID: 1588443 [TBL] [Abstract][Full Text] [Related]
52. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys. Emary WB; Toren PC; Mathews B; Huh K Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey. Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729 [TBL] [Abstract][Full Text] [Related]
54. The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man. Hawkins DR; Weston KT; Chasseaud LF; Darragh A; O'Kelly A Eur J Drug Metab Pharmacokinet; 1980; 5(3):135-43. PubMed ID: 7202431 [TBL] [Abstract][Full Text] [Related]
55. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
56. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs. Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376 [TBL] [Abstract][Full Text] [Related]
57. [Distribution, metabolism and excretion of 14C-MT-141 in rats. I. Distribution, metabolism and excretion after single intravenous administration in male rats]. Komiya I; Ishizuka T; Nishio M; Murata S; Esumi Y; Washino T; Matsunaga K; Mitsugi K; Yokoshima T Jpn J Antibiot; 1984 May; 37(5):927-37. PubMed ID: 6434764 [TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
59. 14C-NaVP and 14C-PEV repeated dose study in rat. Pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester. Bertolino M; Acerbi D; Canali S; Giachetti C; Poli G; Ventura P; Zanolo G Eur J Drug Metab Pharmacokinet; 1998; 23(2):223-9. PubMed ID: 9725486 [TBL] [Abstract][Full Text] [Related]